Document is current

Any future updates will be listed below

LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure

Crossref DOI link: https://doi.org/10.1186/2050-6511-16-S1-A1

Published Online: 2015-09-02

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark